Philadelphia, June 28, 2023 — Carenostics is thrilled to announce the latest addition to their advisory board, John Glaser, PhD, an esteemed leader and seasoned veteran in the healthcare technology sector.
“Dr. Glaser is widely regarded as one of the world’s most influential experts on applying healthcare information and technology to improve efficient delivery of healthcare,” said Bharat Rao, Carenostics’ Co-founder and CEO. “Through his multiple leadership roles in healthcare systems, private industry, and as a leading advisor in government, Dr. Glaser has brought vision and leadership to the application of information technology to improve quality and drive down costs in healthcare, while also addressing concerns of privacy and security. This expertise and insight will be a tremendous asset to Carenostics as we deliver innovative solutions to tackle issues in chronic disease at the point-of-care.”
Dr. Glaser is Executive-in-Residence at the Harvard Medical School and former Senior Vice President of Population Health at Cerner Corporation. Previously, he was Chief Executive Officer of Siemens Health Services and prior, Chief Information Officer at Partners HealthCare.
Dr. Glaser was the Founding Chair of the College of Healthcare Information Management Executives (CHIME) and former president of the Healthcare Information and Management Systems Society (HIMSS). He previously served as Board Chair of the American Telemedicine Association and a former Chair of the Global Agenda Council on Digital Health, World Economic Forum. He was also Senior Advisor to the US Office of the National Coordinator for Health Information Technology, Federal Department of Health and Human Services.
Dr. Glaser currently serves on the boards of Carleton-Willard Village, the Scottsdale Institute, National Committee for Quality Assurance, Lumeon, Wellsheet, and Relatient. He has received numerous industry awards including the Dr. Glaser P. Glaser Innovation Award (established by the School of Biomedical Informatics, University of Texas Health Sciences Center), the William B. Stead Thought Leadership Award (American Medical Informatics Association), and the Lifetime Achievement Award (CHIME).
Dr. Glaser received his Ph.D. from the University of Minnesota. He has written over 200 articles and four books on the strategic application of IT in healthcare. He is on the faculty of the UTHealth School of Biomedical Informatics and the Harvard School of Public Health. He was previously on the faculty of the Wharton School at the University of Pennsylvania.
“I am very excited to be joining Carenostics on their mission to transform healthcare using AI and data,” says Dr. Glaser. “Having seen many innovative solutions over my career, I believe Carenostics’ thoughtful approach of minimizing friction on health systems and supporting clinicians at the point-of-care is the right one to garner widespread adoption of AI in healthcare. Moreover, the Carenostics team has differentiated expertise, having previously deployed healthcare AI solutions at thousands of health systems, and I have full confidence in Dr. Rao’s leadership, given his track record of pioneering AI solutions in healthcare. I am a believer in Carenostics’ team and mission, and look forward to supporting them with my expertise and knowledge.”
As Carenostics continues to break new ground in the area of health technology and personalized care, the strategic guidance from their esteemed board of advisors will play a crucial role in defining their trajectory.
About Carenostics
Carenostics is a mission-driven healthcare AI company founded to improve patient lives by reducing the underdiagnosis, undertreatment, and health inequities of chronic disease. Their vision is to transform healthcare into a data-driven paradigm where readily-available patient data is leveraged to make personalized patient recommendations for diagnostic and therapy decisions — to ultimately improve patient outcomes and reduce healthcare costs.
To achieve these goals, Carenostics has assembled a world-class team of innovators, builders, and researchers with a proven track record of applying AI and ML to tackle challenges across therapeutic areas. Their decades of experience have afforded them broad expertise across healthcare data interoperability and privacy, bias-adjusted machine learning, AI explainability, and clinical research and adoption. Every member of the Carenostics team shares a common passion for improving the lives of millions of chronic disease patients while addressing the inequities in healthcare today.
Business Development / Media Contact: Kanishka Rao, Chief Operating Officer — kanishka@carenostics.com